Managing post-amputation pain with neurostimulation, Neuros Medical raises $20M
U.S. Venture Partners led the round with participation from Boston Scientific, Aperture Venture Partners, Osage University Partners, and JumpStart.
FDA grants Neuros Medical IDE approval to conduct clinical trial for pain management technology for amputees
Neuros Medical, a Cleveland-based medical device company, received an FDA investigational device exemption approval to begin a clinical study on its technology for intractable limb pain management for amputees. According to the company website, the Altius System High Frequency Nerve Block technology “consists of an electrode (also known as a lead) placed around a peripheral […]
presented by
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Pain device maker Neuros Medical’s $3.5M round led by Boston Scientific, Glengary
Neurostimulation device company Neuros Medical Inc. has landed $3.5 million in its second round of funding from a handful of investors including medical device powerhouse Boston Scientific (NYSE:BSX). The company’s device, called the Electrical Nerve Block, comprises a pacemaker-sized generator and a lead that wraps around a peripheral nerve, and delivers stimulation to block pain. […]
Chronic pain device from Neuros Medical gets new investor
Neurostimulation startup Neuros Medical, which is developing a device to block the chronic pain of amputees, has secured a new investor in RiverVest Venture Partners. RiverVest will participate in Neuros’ next funding round, which is expected to close in a few months and is being led by existing investor Glengary. Neuros CEO Jon Snyder has […]
Neuros Medical gets regulatory OK for pilot clinical trial
Neurostimulation startup Neuros Medical has received regulatory approval to begin a pilot clinical trial of its device that blocks pain experienced by amputees. Receiving Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration is an important next step for Cleveland-area Neuros. A successful pilot study could clear the way for a pivotal […]
Neuros Medical looks to close $3.5M round, begin pilot clinical study
Neurostimulation company Neuros Medical is looking to collect a $3.5 million round of investment that it would use to launch a pilot study of its pain-relief device. After earlier this year completing the first successful in-man feasibility study of its pain-blocking device, Willoughby, Ohio-based Neuros plans to conduct a pilot clinical trial that follows a […]
Neuros Medical reports positive results from study of pain-blocking device
Neurotechnology startup Neuros Medical reported encouraging results from the first in-human study of its device that blocks pain for amputation patients. The Willoughby, Ohio, company said that four of five patients in the study reported that Neuros’ device reduced their pain to “zero,” according to a statement from the company. “My pain was gone, something […]
Neuros Medical reports early results from study of pain-blocking device
Neuros Medical announced positive early results in the first-ever in-human feasibility study of its pain-blocking device.
A look at Northeast Ohio’s growing neurotechnology industry
Cleveland Clinic neuromodulation spinoff Intelect Medical may have stealthily exited Cleveland to set up shop in Boston, but the company's recent $78 million sale to Boston Scientific (NYSE: BSX) highlights Northeast Ohio's growing strength in neurotechnology. Here's a brief overview of the key players in Northeast Ohio's rising neurotechnology industry.
Neuros Medical adds former J&J, St. Jude executive to board
Neuros Medical Inc. has added a medical device industry veteran to its board of directors. Scott Drees joins the board as an independent director, according to a statement from Neuros. The Willoughby, Ohio company is developing a neurostimulation device that uses a pacemaker-sized generator and an electrode to stimulate nerves to block pain from amputations, […]
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Neuros Medical gets $1.5M defense award for pain-blocking device
Neuros Medical Inc. plans to double — maybe even triple — its employment over the coming year as it uses a $1.5 million U.S. Department of Defense grant to speed development of its neurostimulation device to block chronic pain. The Willoughby, Ohio, company is developing a device that uses a pacemaker-sized generator and an electrode […]
Queen City Angels defy bad economy, invest in 8 health care companies
Queen City Angels invested in seven life sciences companies and one health information technology company last year, according to its 2009 annual operating report (pdf). The group of accredited investors finished the year with 12 investments, which included three IT companies and one company specializing in advanced materials. In addition, the angel group created a […]
Neuros Medical chooses Battelle to co-develop neurostimulation device for chronic pain
Neuros Medical Inc. has chosen Battelle to help develop its neurostimulation device to block chronic pain. Neuros Medical is developing a "nerve block" system that stimulates nerves to block pain.
Fresh from fundraising, Neuros Medical hires chief technology officer, appoints clinical advisers
Fresh from its first round of fundraising, neurostimulation device developer Neuros Medical Inc. has hired a chief technology officer and appointed a board of advisers.
Neurostimulation device developer Neuros Medical Inc. wins $1.8 million from investors
Neuros Medical Inc., a start-up company that is developing a neurostimulation device to block chronic pain, has landed $1.8 million from several investors during its first round of venture financing. Neuros Medical will use the money to begin product development, hire a chief technology officer and complete clinical studies on its device that stimulates nerves to alleviate pain.